Reuters logo
BRIEF-Xintela to build GMP-facility for stem cell production
September 11, 2017 / 9:06 AM / 10 days ago

BRIEF-Xintela to build GMP-facility for stem cell production

Sept 11 (Reuters) - XINTELA AB

* XINTELA BUILDING OWN GMP-FACILITY FOR STEM CELL PRODUCTION

* ‍ HAS DECIDED TO BRING FORWARD CONSTRUCTION OF ITS OWN FACILITY FOR PRODUCTION OF EQUINE AND HUMAN STEM CELL-BASED ATMPS​

* ‍INITIALLY, STEM CELLS WILL BE PRODUCED FOR CLINICAL STUDIES IN HORSES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below